Export this Data | Chart Risk Level by Product Clear Chart
Add More Filters: Risk_level, Active_ingredient, Use_site, Surface_type, Contact_time, Formulation_type, Date_on_List_N,
ID ▼ | EPA_reg_num | Risk_level | Active_ingredient | Product_name | Company | Use_site | Surface_type | Contact_time | Formulation_type | Follow_directions_for_this_virus | Date_on_List_N | Why_on_List_N |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1076 | 70627-56 | Safer | Hydrogen peroxide | Oxivir™ Tb | Diversey Inc | Healthcare; Institutional | Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) | 1.0 minutes | Ready-to-use; Electrostatic spray | SARS-CoV-2 | 2021-04-13 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1085 | 42182-13 | Increased Risk | Quaternary ammonium; Ethanol (Ethyl alcohol) | Ironman Wipe | Microban Products Company | Healthcare; Institutional; Residential | Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) | 0.1 minutes | Wipe | SARS-CoV-2 | 2021-04-13 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1092 | 6836-442 | Safer | Hydrogen peroxide | DS6835 | Arxada, LLC | Healthcare; Institutional | Hard Nonporous (HN) | 0.5 minutes | Ready-to-use; Electrostatic Spray | SARS-CoV-2 | 2021-04-13 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1099 | 6836-136 | Increased Risk | Quaternary ammonium | Lonza Formulation S-18F | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-13 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1100 | 6836-140 | Increased Risk | Quaternary ammonium | Lonza Formulation S-21F | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-13 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1101 | 6836-152 | Increased Risk | Quaternary ammonium | Lonza Formulation DC-103 | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Ready-to-use | SARS-CoV-2 | 2021-04-13 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1102 | 6836-77 | Increased Risk | Quaternary ammonium | Lonza Formulation S-18 | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-13 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1103 | 6836-381 | Increased Risk | Quaternary ammonium | Lonzagard R-82G | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-13 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1104 | 6836-139 | Increased Risk | Quaternary ammonium | Lonza Formulation R-82F | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-13 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1109 | 6836-75 | Increased Risk | Quaternary ammonium | Lonza Formulation S-21 | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-13 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1110 | 6836-78 | Increased Risk | Quaternary ammonium | Lonza Formulation R-82 | Arxada, LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 1.0 minutes | Dilutable | SARS-CoV-2 | 2021-04-13 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1225 | 1130-15 | Increased Risk | Quaternary ammonium; Isopropanol (Isopropyl alcohol) | Weiman Germicidal Solution | Weiman Products LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) | 2.0 minutes | Ready-to-use | SARS-CoV-2 | 2021-04-13 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1228 | 70144-1 | Increased Risk | Quaternary ammonium; Isopropanol (Isopropyl alcohol) | Opti-Cide 3® | Micro-Scientific LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 2.0 minutes | Ready-to-use | SARS-CoV-2 | 2021-04-13 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1292 | 70271-34 | Increased Risk | Quaternary ammonium | KIK Antibacterial Multipurpose Cleaner I | KIK International LLC | Healthcare; Institutional; Residential | Hard Nonporous (HN); Food Contact Post-Rinse Required (FCR) | 10.0 minutes | Ready-to-use | SARS-CoV-2 | 2021-04-13 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
1540 | 67071-123 | Increased Risk | Quaternary ammonium | Acticide C&D 09 Wipes | Thor Specialties Inc | Healthcare; Institutional; Residential | Hard Nonporous (HN) | 0.25 minutes | Wipe | SARS-CoV-2 | 2021-04-13 | Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim |
Safer Disinfectants is a project of the Maryland Pesticide Education Network
© 2021. All rights reserved.